Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7530146

CCC1c2nc[nH]c2CCN1C(=O)OC.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 3/20 0.45
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
MTNR1B P49286 2/20 0.33
MTNR1A P48039 1/20 0.33
PDE4D Q08499 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
CHRNB2 P17787 1/20 0.30
CHRNA4 P43681 1/20 0.30
P2RX7 Q99572 1/20 0.30
DPP4 P27487 1/20 0.30
DPP8 Q6V1X1 1/20 0.30
DPP9 Q86TI2 1/20 0.30
DPP7 Q9UHL4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7525401 0.92 AOC3 (0.43) AOC3HRH4HRH3MTNR1BMTNR1A
Trifluoroacetic Acid SCHEMBL7572001 0.89 AOC3 (0.43) AOC3HRH4HRH3L3MBTL1ALDH1A1
Trifluoroacetic Acid SCHEMBL7526771 0.87 AOC3 (0.41) AOC3HRH4HRH3CYP3A4CYP2D6
SCHEMBL7572011 0.86 AOC3 (0.43) AOC3P2RX7DPP4DPP8DPP9
Trifluoroacetic Acid SCHEMBL7525105 0.85 AOC3 (0.44) AOC3HRH4HRH3ALDH1A1POLB
Trifluoroacetic Acid SCHEMBL7529674 0.85 AOC3 (0.54) AOC3
Trifluoroacetic Acid SCHEMBL7527035 0.83 AOC3 (0.50) AOC3
Trifluoroacetic Acid SCHEMBL7525097 0.81 AOC3 (0.48) AOC3HRH4HRH3ALDH1A1POLB
SCHEMBL7534337 0.80 AOC3 (0.56) AOC3ALDH1A1POLB
SCHEMBL7534329 0.79 AOC3 (0.48) AOC3ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020198189-A1 Treatment or prophylaxis of Semicarbazide-sensitive amine oxidase (SSAO) mediated complications in mammals including humans BIOVITRUM AB (SE) 2002-12-26 US disclosed
WO-2002038153-A1 NEW USE OF 4, 5, 6, 7-TETRAHYDROIMIDAZO-[4,5-C]PYRIDINE DERIVATIVES BIOVITRUM AB (SE) 2002-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198189-A1 Treatment or prophylaxis of Semicarbazide-sensitive amine oxidase (SSAO) mediated complications in mammals including humans AOC3, AOC2, AOC1 AOC3 1/4885HRH4 148/4885HRH3 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.